Transfer factor: failure to transfer reactivity in normal human subjects.

Por Spitler, L E
Publicado em 1980

Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Por Scott, C F, Spitler, L E
Publicado em 1983

Treatment of immune deficiency.

Por Fudenberg, H. H., Spitler, L. E., Levin, A. S.
Publicado em 1972

Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

Por Gonzalez, R L, Dau, P C, Spitler, L E
Publicado em 1979

The effect of levamisole on cellular immunity in multiple sclerosis.

Por Dau, P C, Johnson, K P, Spitler, L E
Publicado em 1976

Wiskott-Aldrich Syndrome, A Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor

Por Levin, A. S., Spitler, L. E., Stites, D. P., Fudenberg, H. H.
Publicado em 1970

Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids.

Por Levy, J A, Lee, H M, Kawahata, R T, Spitler, L E
Publicado em 1984

Transfer factor therapy in ataxia--telangiectasia.

Por Berkel, A I, Ersoy, F, Epstein, L B, Spitler, L E
Publicado em 1977

Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.

Por Harkonen, S, Scannon, P, Mischak, R P, Spitler, L E, Foxall, C, Kennedy, D, Greenberg, R
Publicado em 1988

Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

Por Levin, A S, Byers, V S, Fudenberg, H H, Wybran, J, Hackett, A J, Johnston, J O, Spitler, L E
Publicado em 1975